메뉴 건너뛰기




Volumn 30, Issue , 2015, Pages i150-i158

Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: Who needs what and for how long?

Author keywords

ANCA; GPA; maintenance; MPA; vasculitis

Indexed keywords

ABATACEPT; AZATHIOPRINE; BELIMUMAB; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ETANERCEPT; GLUCOCORTICOID; HLA DR ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA; IMMUNOSUPPRESSIVE AGENT;

EID: 84926670574     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu397     Document Type: Review
Times cited : (20)

References (60)
  • 1
    • 77952573197 scopus 로고    scopus 로고
    • ANCA disease: Where is this field heading
    • Falk RJ, Jennette JC. ANCA disease: where is this field heading. J Am Soc Nephrol 2010; 21: 745-752
    • (2010) J Am Soc Nephrol , vol.21 , pp. 745-752
    • Falk, R.J.1    Jennette, J.C.2
  • 2
    • 84920235395 scopus 로고
    • Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis
    • van der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-429
    • (1985) Lancet , vol.1 , pp. 425-429
    • Van Der Woude, F.J.1    Rasmussen, N.2    Lobatto, S.3
  • 3
    • 0023878734 scopus 로고
    • Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis
    • Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-1657
    • (1988) N Engl J Med , vol.318 , pp. 1651-1657
    • Falk, R.J.1    Jennette, J.C.2
  • 4
    • 0031985125 scopus 로고    scopus 로고
    • Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis
    • Jennette JC, Falk RJ. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transplant 1998; 13 (Suppl 1): 16-20
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 16-20
    • Jennette, J.C.1    Falk, R.J.2
  • 5
    • 0036790387 scopus 로고    scopus 로고
    • Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
    • Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 955-963
    • (2002) J Clin Invest , vol.110 , pp. 955-963
    • Xiao, H.1    Heeringa, P.2    Hu, P.3
  • 6
    • 0020656868 scopus 로고
    • Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
    • Fauci AS, Haynes BF, Katz P et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85
    • (1983) Ann Intern Med , vol.98 , pp. 76-85
    • Fauci, A.S.1    Haynes, B.F.2    Katz, P.3
  • 7
    • 0038122889 scopus 로고    scopus 로고
    • A randomized trial of maintenance therapy for vasculitis associated with antineutophil cytoplasmic autoantibodies
    • Jayne D, Rasmussen N, Andrassy K et al. A randomized trial of maintenance therapy for vasculitis associated with antineutophil cytoplasmic autoantibodies. N Engl J Med 2003; 349: 36-44
    • (2003) N Engl J Med , vol.349 , pp. 36-44
    • Jayne, D.1    Rasmussen, N.2    Andrassy, K.3
  • 8
    • 46849114754 scopus 로고    scopus 로고
    • Outcomes from studies of antineutrophil cytoplasmic antibody associated vasculitis: A systemic review by the European League Against Rheumatism systemic vasculitis task force
    • Mukhtyar C, Flossman O, Hellmich B et al. Outcomes from studies of antineutrophil cytoplasmic antibody associated vasculitis: a systemic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 2008; 67:1004-1010
    • (2008) Ann Rheum Dis , vol.67 , pp. 1004-1010
    • Mukhtyar, C.1    Flossman, O.2    Hellmich, B.3
  • 9
    • 84926630781 scopus 로고    scopus 로고
    • Maintenance of clinical remission in ANCA associated vasculitis
    • Luqmani R. Maintenance of clinical remission in ANCA associated vasculitis. Nat Rev Rheumatol 2012; 9: 188-193
    • (2012) Nat Rev Rheumatol , vol.9 , pp. 188-193
    • Luqmani, R.1
  • 10
    • 84865494931 scopus 로고    scopus 로고
    • Complications of long term therapy for ANCA-associated vasculitis
    • Wall N, Harper L. Complications of long term therapy for ANCA-associated vasculitis. Nat Rev Nephrol 2012; 8: 523-532
    • (2012) Nat Rev Nephrol , vol.8 , pp. 523-532
    • Wall, N.1    Harper, L.2
  • 11
    • 84891731230 scopus 로고    scopus 로고
    • Kidney diseases improving global outcomes (KDIGO) clinical practice guideline on glomerulonefritis
    • Kidney diseases improving global outcomes (KDIGO) clinical practice guideline on glomerulonefritis. Kidney Int Suppl 2012; 2: 233-239
    • (2012) Kidney Int Suppl , vol.2 , pp. 233-239
  • 12
    • 84856383829 scopus 로고    scopus 로고
    • Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
    • Walsh M, Flossman O, Berden A et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012; 64: 542-548
    • (2012) Arthritis Rheum , vol.64 , pp. 542-548
    • Walsh, M.1    Flossman, O.2    Berden, A.3
  • 13
    • 67349163354 scopus 로고    scopus 로고
    • BSR and BHPR guidelines for the management of adults with ANCA-associated vasculitis
    • Lapraik C, Watts R, Bacon P et al. BSR and BHPR guidelines for the management of adults with ANCA-associated vasculitis. Rheumatology 2007; 46: 1-11
    • (2007) Rheumatology , vol.46 , pp. 1-11
    • Lapraik, C.1    Watts, R.2    Bacon, P.3
  • 14
    • 0024999139 scopus 로고
    • Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre
    • Cohen Tervaert JW, Huitema MG, Hene RJ et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709-711
    • (1990) Lancet , vol.336 , pp. 709-711
    • Cohen Tervaert, J.W.1    Huitema, M.G.2    Hene, R.J.3
  • 15
    • 0028343415 scopus 로고
    • Antineutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential
    • Kallenberg CG, Brouwer E, Weening JJ et al. Antineutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15
    • (1994) Kidney Int , vol.46 , pp. 1-15
    • Kallenberg, C.G.1    Brouwer, E.2    Weening, J.J.3
  • 16
    • 27644437166 scopus 로고    scopus 로고
    • Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody associated small vessel vasculitis
    • Hogan SL, Falk RJ, Chin H et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody associated small vessel vasculitis. Ann Intern Med 2005; 143: 621-631
    • (2005) Ann Intern Med , vol.143 , pp. 621-631
    • Hogan, S.L.1    Falk, R.J.2    Chin, H.3
  • 17
    • 42549147680 scopus 로고    scopus 로고
    • 30 Year follow up of 400 patients with ANCA associated vasculitis: Predictors of relapse and survival
    • Salama AD, Ryba M, Levy J et al. 30 Year follow up of 400 patients with ANCA associated vasculitis: predictors of relapse and survival. J Am Soc Nephrol 2006; 17: 732A
    • (2006) J Am Soc Nephrol , vol.17 , pp. 732A
    • Salama, A.D.1    Ryba, M.2    Levy, J.3
  • 18
    • 69549107649 scopus 로고    scopus 로고
    • The clinical course of ANCA small vessel vasculitis on chronic dialysis
    • Lionaki S, Hogan SL, Jennette CE et al. The clinical course of ANCA small vessel vasculitis on chronic dialysis. Kidney Int 2009; 76: 644-651
    • (2009) Kidney Int , vol.76 , pp. 644-651
    • Lionaki, S.1    Hogan, S.L.2    Jennette, C.E.3
  • 19
    • 34250754821 scopus 로고    scopus 로고
    • Recurrence and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis
    • Weidanz F, Day CJ, Hewins P et al. Recurrence and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kid Dis 2007; 50: 36-46
    • (2007) Am J Kid Dis , vol.50 , pp. 36-46
    • Weidanz, F.1    Day, C.J.2    Hewins, P.3
  • 20
    • 61449238213 scopus 로고    scopus 로고
    • EULAR recommendations for the management of primary small and medium vessel vasculitis
    • Mukhtyar C, Guillevin L, Cid MC et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009; 68: 310-317
    • (2009) Ann Rheum Dis , vol.68 , pp. 310-317
    • Mukhtyar, C.1    Guillevin, L.2    Cid, M.C.3
  • 21
    • 84855168545 scopus 로고    scopus 로고
    • Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-A meta-analysis
    • Tomasson G, Grayson PC, Mahr AD et al. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-A meta-analysis. Rheumatology 2012; 51:100-109
    • (2012) Rheumatology , vol.51 , pp. 100-109
    • Tomasson, G.1    Grayson, P.C.2    Mahr, A.D.3
  • 22
    • 33645379412 scopus 로고    scopus 로고
    • HLA-DR antigens are associated with ANCA-associated vasculitis and relapse during follow up in PR3 but not in MPO-ANCA related vasculitis
    • Stassen P, Sanders JS, Lems S et al. HLA-DR antigens are associated with ANCA-associated vasculitis and relapse during follow up in PR3 but not in MPO-ANCA related vasculitis. Kidney Blood Press Res 2003; 26: 277
    • (2003) Kidney Blood Press Res , vol.26 , pp. 277
    • Stassen, P.1    Sanders, J.S.2    Lems, S.3
  • 23
    • 84864014453 scopus 로고    scopus 로고
    • Genetically distinct subsets within ANCA-associated vasculitis
    • Lyons PA, Rayner TF, Trivedi S et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012; 367: 214-232
    • (2012) N Engl J Med , vol.367 , pp. 214-232
    • Lyons, P.A.1    Rayner, T.F.2    Trivedi, S.3
  • 24
    • 84922202111 scopus 로고    scopus 로고
    • Long-term follow-up of cyclophos-phamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis
    • Walsh M, Faurschou M, Berden A et al. Long-term follow-up of cyclophos-phamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis. Clin J Am Soc Nephrol 2014; 9: 1571-1576
    • (2014) Clin J Am Soc Nephrol , vol.9 , pp. 1571-1576
    • Walsh, M.1    Faurschou, M.2    Berden, A.3
  • 25
    • 0036267256 scopus 로고    scopus 로고
    • Predictors of survival and organ damage in Wegener's granulomatosis
    • Koldingnes W, Nossent H. Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology 2002; 41: 572-581
    • (2002) Rheumatology , vol.41 , pp. 572-581
    • Koldingnes, W.1    Nossent, H.2
  • 26
    • 23644455521 scopus 로고    scopus 로고
    • Randomized trial of cyclophos-phamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
    • de Groot K, Rasmussen N, Bacon PA et al. Randomized trial of cyclophos-phamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52: 2461-2469
    • (2005) Arthritis Rheum , vol.52 , pp. 2461-2469
    • De Groot, K.1    Rasmussen, N.2    Bacon, P.A.3
  • 27
    • 84881171976 scopus 로고    scopus 로고
    • Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear
    • Walsh M, Casian A, Flossmann O et al. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 2013; 84: 397-402
    • (2013) Kidney Int , vol.84 , pp. 397-402
    • Walsh, M.1    Casian, A.2    Flossmann, O.3
  • 28
    • 84907931926 scopus 로고    scopus 로고
    • Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: Single center results of a stepwise escalation of immunosuppression
    • de Joode AAE, Sanders JSF, Smid WM et al. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single center results of a stepwise escalation of immunosuppression. J Clin Apher 2014; 29: 266-272
    • (2014) J Clin Apher , vol.29 , pp. 266-272
    • De Joode Aae1    Jsf, S.2    Smid, W.M.3
  • 29
    • 77955236779 scopus 로고    scopus 로고
    • Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis
    • Walsh M, Merkel PA, Mahr A et al. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res 2010; 62: 1166-1173
    • (2010) Arthritis Care Res , vol.62 , pp. 1166-1173
    • Walsh, M.1    Merkel, P.A.2    Mahr, A.3
  • 30
    • 0029946561 scopus 로고    scopus 로고
    • Trimethoprim-sulfa-methoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis
    • Stegeman CA, Cohen Tevaert JW, de Jong PE et al. Trimethoprim-sulfa-methoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996; 335: 16-20
    • (1996) N Engl J Med , vol.335 , pp. 16-20
    • Stegeman, C.A.1    Cohen Tevaert, J.W.2    De Jong, P.E.3
  • 31
    • 0002737870 scopus 로고
    • Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wege-ner's granulomatosis
    • Stegeman CA, Cohen Tevaert JW, Sluiter WJ et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wege-ner's granulomatosis. Ann Intern Med 1994; 120: 12-17
    • (1994) Ann Intern Med , vol.120 , pp. 12-17
    • Stegeman, C.A.1    Cohen Tevaert, J.W.2    Sluiter, W.J.3
  • 32
    • 84885191711 scopus 로고    scopus 로고
    • Renal survival in proteinase 3 and myeoloperoxidase ANCA-associated vasculitis
    • de Joode AAE, Sanders JS, Stegeman CA. Renal survival in proteinase 3 and myeoloperoxidase ANCA-associated vasculitis. Clin J Am Soc Nephrol 2013; 8: 1709
    • (2013) Clin J Am Soc Nephrol , vol.8 , pp. 1709
    • De Joode Aae1    Sanders, J.S.2    Stegeman, C.A.3
  • 33
    • 84864415335 scopus 로고    scopus 로고
    • Progression and management of Wegener's granulomatosis in the head and neck
    • Taylor SC, Clayburgh DR, Rosenbaum JT et al. Progression and management of Wegener's granulomatosis in the head and neck. Laryngoscope 2012; 122: 1695-1700
    • (2012) Laryngoscope , vol.122 , pp. 1695-1700
    • Taylor, S.C.1    Clayburgh, D.R.2    Rosenbaum, J.T.3
  • 34
    • 38149112725 scopus 로고    scopus 로고
    • Malignancies in Wegener's granulomatosis: Incidence and relation to cyclophosphamide therapy in a cohort of 293 patients
    • Faurschou M, Sorensen IJ, Mellemkaer L et al. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rhematol 2008; 35: 100-105
    • (2008) J Rhematol , vol.35 , pp. 100-105
    • Faurschou, M.1    Sorensen, I.J.2    Mellemkaer, L.3
  • 35
    • 0037380194 scopus 로고    scopus 로고
    • Outcome of ANCA associated renal vasculitis: A 5-year retrospective study
    • Booth AD, Almond MK, Burns A et al. Outcome of ANCA associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41: 776-784
    • (2003) Am J Kidney Dis , vol.41 , pp. 776-784
    • Booth, A.D.1    Almond, M.K.2    Burns, A.3
  • 36
    • 78649728808 scopus 로고    scopus 로고
    • Mycophenolate mofetil, vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: A randomized trial
    • Hiemstra TF, Walsh M, Mahr A et al. Mycophenolate mofetil, vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. JAMA 2010; 304: 2381-2388
    • (2010) JAMA , vol.304 , pp. 2381-2388
    • Hiemstra, T.F.1    Walsh, M.2    Mahr, A.3
  • 37
    • 84889685980 scopus 로고    scopus 로고
    • The characterisation and determinants of quality of life in ANCA associated vasculitis
    • Basu N, McClean A, Harper L et al. The characterisation and determinants of quality of life in ANCA associated vasculitis. Ann Rheum Dis 2014; 73: 207-211
    • (2014) Ann Rheum Dis , vol.73 , pp. 207-211
    • Basu, N.1    McClean, A.2    Harper, L.3
  • 38
    • 79959979797 scopus 로고    scopus 로고
    • Health related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody associated vasculitis
    • Walsh M, Muhktyar C, Mahr A et al. Health related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody associated vasculitis. Arthritis Care Res 2011; 63: 1055-1061
    • (2011) Arthritis Care Res , vol.63 , pp. 1055-1061
    • Walsh, M.1    Muhktyar, C.2    Mahr, A.3
  • 39
    • 0030464106 scopus 로고    scopus 로고
    • Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granuloma-tosis: Methotrexate versus trimethoprim/sulfamethoxazole
    • de Groot K, Reinhold-Keller E, Tatsis E et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granuloma-tosis: methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996; 39: 2052-2061
    • (1996) Arthritis Rheum , vol.39 , pp. 2052-2061
    • De Groot, K.1    Reinhold-Keller, E.2    Tatsis, E.3
  • 40
    • 58149180323 scopus 로고    scopus 로고
    • Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
    • Pagnoux C, Mahr A, Hamidou MA et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008; 359: 2790-2803
    • (2008) N Engl J Med , vol.359 , pp. 2790-2803
    • Pagnoux, C.1    Mahr, A.2    Hamidou, M.A.3
  • 41
    • 0037097601 scopus 로고    scopus 로고
    • High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low dose methotrexate
    • Reinhold-Keller E, Fink COE, Herlyn K et al. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low dose methotrexate. Arthritis Rheum 2002; 47: 326-332
    • (2002) Arthritis Rheum , vol.47 , pp. 326-332
    • Reinhold-Keller, E.1    Coe, F.2    Herlyn, K.3
  • 42
    • 12544253745 scopus 로고    scopus 로고
    • Etanercept plus standard therapy for Wegener's granulomatosis
    • The Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005; 352: 351-361
    • (2005) N Engl J Med , vol.352 , pp. 351-361
  • 43
    • 1442350027 scopus 로고    scopus 로고
    • Maintenance of remission with le-flunomide in Wegener's granulomatosis
    • Metzler C, Fink C, Lamprecht P et al. Maintenance of remission with le-flunomide in Wegener's granulomatosis. Rheumatology 2004; 43: 315-320
    • (2004) Rheumatology , vol.43 , pp. 315-320
    • Metzler, C.1    Fink, C.2    Lamprecht, P.3
  • 44
    • 34447323863 scopus 로고    scopus 로고
    • Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wege-ner's granulomatosis
    • Metzler C, Miehle N, Manger K et al. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wege-ner's granulomatosis. Rheumatology 2007; 46: 1087-1091
    • (2007) Rheumatology , vol.46 , pp. 1087-1091
    • Metzler, C.1    Miehle, N.2    Manger, K.3
  • 45
    • 84886240857 scopus 로고    scopus 로고
    • Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients
    • Guillevin L, Pagnoux C, Karras A et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients. Presse Med 2013; 42: 679
    • (2013) Presse Med , vol.42 , pp. 679
    • Guillevin, L.1    Pagnoux, C.2    Karras, A.3
  • 46
    • 0031664888 scopus 로고    scopus 로고
    • Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glom-erulonephritis
    • Franssen CFM, Stegeman CA, Oost-Kort WW et al. Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glom-erulonephritis. J Am Soc Nephrol 1998; 9: 1915-1923
    • (1998) J Am Soc Nephrol , vol.9 , pp. 1915-1923
    • Cfm, F.1    Stegeman, C.A.2    Oost-Kort, W.W.3
  • 47
    • 84886242612 scopus 로고    scopus 로고
    • Randomized clinical trial of extended versus standard azathioprine maintenance therapy in newly diagnosed positive PR3-ANCA vasculitis patients at high-risk for disease relapse
    • (abstract)
    • de Joode AAE, Sanders JS, Cohen Tervaert JW et al. Randomized clinical trial of extended versus standard azathioprine maintenance therapy in newly diagnosed positive PR3-ANCA vasculitis patients at high-risk for disease relapse. Presse Med 2013; 42: 680 (abstract)
    • (2013) Presse Med , vol.42 , pp. 680
    • De Joode Aae1    Sanders, J.S.2    Cohen Tervaert, J.W.3
  • 48
    • 77954651554 scopus 로고    scopus 로고
    • Rituximab versus cyclophosphamide for ANCA associated vasculitis
    • Stone JH, Merkel PA, Spiera R et al. Rituximab versus cyclophosphamide for ANCA associated vasculitis. N Eng J Med 2010; 363: 221-232
    • (2010) N Eng J Med , vol.363 , pp. 221-232
    • Stone, J.H.1    Merkel, P.A.2    Spiera, R.3
  • 49
    • 84894316831 scopus 로고    scopus 로고
    • Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: A multicentre retrospective study on 80 patients
    • Charles P, Neel A, Tieulie N et al. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Rheumatology 2014; 53: 532-539
    • (2014) Rheumatology , vol.53 , pp. 532-539
    • Charles, P.1    Neel, A.2    Tieulie, N.3
  • 50
    • 77954632414 scopus 로고    scopus 로고
    • Rituximab versus cyclo-phosphamide in ANCA-associated renal vasculitis
    • Jones RB, Cohen Tervaert JW, Hauser T et al. Rituximab versus cyclo-phosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010; 363: 211-220
    • (2010) N Engl J Med , vol.363 , pp. 211-220
    • Jones, R.B.1    Cohen Tervaert, J.W.2    Hauser, T.3
  • 51
    • 84922286333 scopus 로고    scopus 로고
    • Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis
    • Pendergraft WF, Cortazar FB, Wenger J et al. Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis. Clin J Am Soc Nephrol 2014; 9: 736-744
    • (2014) Clin J Am Soc Nephrol , vol.9 , pp. 736-744
    • Pendergraft, W.F.1    Cortazar, F.B.2    Wenger, J.3
  • 52
    • 84908576790 scopus 로고    scopus 로고
    • Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis
    • Guillevin L, Pagnoux C, Karras A et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Eng J Med 2014; 371: 1771-1780.
    • (2014) N Eng J Med , vol.371 , pp. 1771-1780
    • Guillevin, L.1    Pagnoux, C.2    Karras, A.3
  • 53
    • 77955767712 scopus 로고    scopus 로고
    • Rituximab as maintenance therapy for ANCA-associated vasculitis
    • Rhee EP, Laliberte KA, Niles JL. Rituximab as maintenance therapy for ANCA-associated vasculitis. Clin J Am Soc Nephrol 2010; 5: 1394-1400
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 1394-1400
    • Rhee, E.P.1    Laliberte, K.A.2    Niles, J.L.3
  • 54
    • 84868087895 scopus 로고    scopus 로고
    • Rituximab for maintaining remission in relapsing antineutrophil cytoplasmic antibody-associated vascu-litis
    • Smith RM, Jones GB, Guerry MJ et al. Rituximab for maintaining remission in relapsing antineutrophil cytoplasmic antibody-associated vascu-litis. Arthritis Rheum 2012; 64: 3760-3769
    • (2012) Arthritis Rheum , vol.64 , pp. 3760-3769
    • Smith, R.M.1    Jones, G.B.2    Guerry, M.J.3
  • 55
    • 84902251458 scopus 로고    scopus 로고
    • An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)
    • Langford CA, Monach PA, Specks U et al. An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's). Ann Rheum Dis 2014; 73: 1376-1379
    • (2014) Ann Rheum Dis , vol.73 , pp. 1376-1379
    • Langford, C.A.1    Monach, P.A.2    Specks, U.3
  • 56
    • 45849124232 scopus 로고    scopus 로고
    • BSR/BHPR guideline for the disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British association of dermatologists
    • Chakravart K, Mc Donald H, Pullar T et al. BSR/BHPR guideline for the disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British association of dermatologists. Rheumatology 2008; 47: 924-925
    • (2008) Rheumatology , vol.47 , pp. 924-925
    • Chakravart, K.1    Mc Donald, H.2    Pullar, T.3
  • 57
    • 84886242180 scopus 로고    scopus 로고
    • Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatment of adult, anti-neutrophil cytoplasm antibody-associated necrotizing vasculitides
    • Charles P, Bienvenu B, Bonnotte B et al. Rituximab: recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatment of adult, anti-neutrophil cytoplasm antibody-associated necrotizing vasculitides. Presse Med 2013; 42: 1317-1330
    • (2013) Presse Med , vol.42 , pp. 1317-1330
    • Charles, P.1    Bienvenu, B.2    Bonnotte, B.3
  • 58
    • 84868012506 scopus 로고    scopus 로고
    • Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center
    • Cartin-Ceba R, Golbin JM, Keogh KA et al. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center. Arthritis Rheum 2012; 64: 3770-3778
    • (2012) Arthritis Rheum , vol.64 , pp. 3770-3778
    • Cartin-Ceba, R.1    Golbin, J.M.2    Keogh, K.A.3
  • 59
    • 0030062483 scopus 로고    scopus 로고
    • Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic poly-angiitis and glomerulonephritis
    • Nachman PH, Hogan SL, Jennette JC et al. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic poly-angiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 33-39
    • (1996) J Am Soc Nephrol , vol.7 , pp. 33-39
    • Nachman, P.H.1    Hogan, S.L.2    Jennette, J.C.3
  • 60
    • 38149065308 scopus 로고    scopus 로고
    • Intravenous immunoglobu-lins for relapses of systemic vasculitides associated with antineutro-phil cytoplasmic antoantibodies: Results of a multicenter, prospective open-label study of twenty-two patients
    • Martinez V, Cohen P, Pagnoux C et al. Intravenous immunoglobu-lins for relapses of systemic vasculitides associated with antineutro-phil cytoplasmic antoantibodies: results of a multicenter, prospective open-label study of twenty-two patients. Arthritis Rheum 2008; 58: 308-317
    • (2008) Arthritis Rheum , vol.58 , pp. 308-317
    • Martinez, V.1    Cohen, P.2    Pagnoux, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.